Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Louis, David
Item TypeName
Academic Article Neoadjuvant temozolomide followed by complete resection of a 1p- and 19q-deleted anaplastic oligoastrocytoma: case study.
Academic Article Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment.
Academic Article A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy.
Academic Article International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors.
Academic Article Oncolytic virus-mediated manipulation of DNA damage responses: synergy with chemotherapy in killing glioblastoma stem cells.
Academic Article MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance.
Academic Article Phase I study pilot arms of radiotherapy and carmustine with temozolomide for anaplastic astrocytoma (Radiation Therapy Oncology Group 9813): implications for studies testing initial treatment of brain tumors.
Academic Article MSH6 inactivation and emergent temozolomide resistance in human glioblastomas.
Academic Article Initial treatment patterns over time for anaplastic oligodendroglial tumors.
Concept Dacarbazine
Academic Article Case 38-2016. A 52-Year-Old Woman with Recurrent Oligodendroglioma.
Academic Article Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma.
Search Criteria
  • Dacarbazine
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.